BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6265359)

  • 41. Cell-mediated immunity to vesicular stomatitis virus infections in mice.
    Zinkernagel RM; Adler B; Holland JJ
    Exp Cell Biol; 1978; 46(1-2):53-70. PubMed ID: 202522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR; Mackett M; Lefrancois L; Lyles DS; Moss B
    J Exp Med; 1986 Jun; 163(6):1529-38. PubMed ID: 3011949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells.
    Puddington L; Bevan MJ; Rose JK; Lefrançois L
    J Virol; 1986 Nov; 60(2):708-17. PubMed ID: 3022003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
    Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
    Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?
    Bachmann MF; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1995 Dec; 25(12):3445-51. PubMed ID: 8566036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Localization of T helper cell epitopes in the vesicular stomatitis virus: the nucleoprotein is responsible for serotype cross-reactive T help.
    Burkhart C; Freer G; Steinhoff U; Li Y; Bishop DH; Zinkernagel RM; Hengartner H
    Viral Immunol; 1994; 7(3):103-11. PubMed ID: 7541205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The spatial relationship of the viral and H-2 antigens recognized by anti-viral CTLs.
    Hale AH
    Immunogenetics; 1980; 10(5):469-79. PubMed ID: 22457920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus.
    Burkhart C; Freer G; Castro R; Adorini L; Wiesmüller KH; Zinkernagel RM; Hengartner H
    J Virol; 1994 Mar; 68(3):1573-80. PubMed ID: 7508998
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Minimal molecular requirements for reactivity of tumor cells with T cells.
    Hale AH; Lyles DS; Paulus LK; Ruebush MJ
    J Immunol; 1980 May; 124(5):2063-70. PubMed ID: 6245133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. VSV G protein induces murine cytolytic T lymphocytes.
    Reiss CS; Chen SS; Huang AS; Doherty R
    Microb Pathog; 1986 Jun; 1(3):261-7. PubMed ID: 2854599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytotoxic T lymphocytes recognize determinants on the BALB/c-H-2Ld molecule controlled by alpha 1 and alpha 2 but not alpha 3 external domains.
    Stroynowski I; Orn A; Goodenow RS; McMillan M; Forman J; Brayton PR; Frelinger J; Hood L
    Immunogenetics; 1984; 20(2):141-54. PubMed ID: 6205987
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elicitation of natural killer cells in beige mice by infection with vesicular stomatitis virus.
    McKinnon KP; Hale AH; Ruebush MJ
    Infect Immun; 1981 Apr; 32(1):204-10. PubMed ID: 6163720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell-mediated immunity to herpes simplex virus: induction of cytotoxic T lymphocyte responses by viral antigens incorporated into liposomes.
    Lawman MJ; Naylor PT; Huang L; Courtney RJ; Rouse BT
    J Immunol; 1981 Jan; 126(1):304-8. PubMed ID: 6969745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
    Hudrisier D; Oldstone MB; Gairin JE
    Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T cell hybridomas define the class II MHC-restricted response to vesicular stomatitis virus infection.
    Petrarca MA; Reiss CS; Diamond DC; Boni J; Burakoff SJ; Faller DV
    Microb Pathog; 1988 Nov; 5(5):319-32. PubMed ID: 2853279
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of glycosylation in the H-2-restricted cytolysis of virus-infected cells.
    Black PL; Vitetta ES; Forman J; Kang CY; May RD; Uhr JW
    Eur J Immunol; 1981 Jan; 11(1):48-55. PubMed ID: 6260509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T cell priming against vesicular stomatitis virus analyzed in situ: red pulp macrophages, but neither marginal metallophilic nor marginal zone macrophages, are required for priming CD4+ and CD8+ T cells.
    Ciavarra RP; Buhrer K; Van Rooijen N; Tedeschi B
    J Immunol; 1997 Feb; 158(4):1749-55. PubMed ID: 9029112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus.
    McAdam AJ; Farkash EA; Gewurz BE; Sharpe AH
    J Virol; 2000 Jan; 74(1):203-8. PubMed ID: 10590107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Priming antiviral cytotoxic T lymphocytes: requirement for CD4+ cells is dependent on the antigen presenting cell in vivo.
    Ciavarra RP; Tedeschi B
    Cell Immunol; 1994 Aug; 157(1):132-43. PubMed ID: 7913664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The interactionof antiody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies.
    Lefrancios L; Lyles DS
    Virology; 1982 Aug; 121(1):157-67. PubMed ID: 6180550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.